Chinese peptide sourcing carries its own set of considerations, including longer shipping times, customs clearance uncertainties, communication barriers, and varying manufacturing standards
FDA approval impact When Eli Lilly secures FDA approval, the commercial product will likely launch at $1,000 to $1,500 per month
Unsupervised "off-label" use, particularly for quick cosmetic weight loss, bypassing specialist oversight, can lead to severe and life-threatening side effects
For the clinician , it represents something even more profound: The opportunity to guide transformation not merely manage numbers
Tirzepatide (Mounjaro, Zepbound) works through a related but distinct mechanism as a dual GIP/GLP-1 receptor agonist